BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15231763)

  • 21. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.
    Bocanegra R; Najvar LK; Hernandez S; McCarthy DI; Graybill JR
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5139-41. PubMed ID: 16304187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    Gahn B; Schub N; Repp R; Gramatzki M
    Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New type of effective antifungal treatment identified.
    Bosch X
    Lancet Oncol; 2004 Nov; 5(11):645. PubMed ID: 15536684
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.
    Voitl P; Scheibenpflug C; Weber T; Janata O; Rokitansky AM
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):632-4. PubMed ID: 12226700
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
    Kriván G; Sinkó J; Nagy IZ; Goda V; Reményi P; Bátai A; Lueff S; Kapás B; Réti M; Tremmel A; Masszi T
    Acta Biomed; 2006; 77 Suppl 2():17-21. PubMed ID: 16918062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    Vagace JM; Sanz-Rodriguez C; Casado MS; Alonso N; Garcia-Dominguez M; de la Llana FG; Zarallo L; Fajardo M; Bajo R
    BMC Infect Dis; 2007 May; 7():40. PubMed ID: 17493279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
    Kendirli T; Ciftçi E; Ince E; Oncel S; Dalgiç N; Güriz H; Unal E; Dogru U
    Mycoses; 2006 May; 49(3):251-3. PubMed ID: 16681821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined therapies in a murine model of blastoschizomycosis.
    Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2608-10. PubMed ID: 17452487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichosporon inkin peritonitis treated with caspofungin.
    Madariaga MG; Tenorio A; Proia L
    J Clin Microbiol; 2003 Dec; 41(12):5827-9. PubMed ID: 14662994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation.
    Abdala E; Lopes RI; Chaves CN; Heins-Vaccari EM; Shikanai-Yasuda MA
    Transpl Infect Dis; 2005; 7(3-4):162-5. PubMed ID: 16390408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modern antifungal therapy for neutropenic fever.
    Corey M
    Curr Hematol Malig Rep; 2006 Jun; 1(2):95-100. PubMed ID: 20425338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspofungin versus liposomal amphotericin B: are they really comparable?
    Sekine L; Humbwavali J; Wolff FH; Barcellos NT
    Pediatr Infect Dis J; 2010 Oct; 29(10):985-6; author reply 986-7. PubMed ID: 20859182
    [No Abstract]   [Full Text] [Related]  

  • 38. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP
    Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract]   [Full Text] [Related]  

  • 39. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    Torres A; Serrano J; Rojas R; Martín V; Martín C; Tabares S; Molina JR; Capote M; Martínez F; Gómez P; Sánchez-García J
    Eur J Haematol; 2010 Mar; 84(3):271-3. PubMed ID: 19878274
    [No Abstract]   [Full Text] [Related]  

  • 40. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.